Burroughs Wellcome, the developer and maker of AZT, a drug to treat persons afflicted with AIDS, charges each patient $6,500 annually-more than many AIDS patients can afford because they are unable to work. This is an example of the
Manufacturer recognizing its:

Question

Quizplus · Accepted Answer

Burroughs Wellcome's practice of charging $6,500 annually for AZT demonstrates its profit responsibility. While the cost of research and development, and production costs may be high, pricing the drug at a level that many AIDS patients are unable to afford raises ethical concerns. However, the company is within its rights to prioritize profit-making, but pricing the drug at a level affordable to the target market would still be an economically viable option.

Burroughs Wellcome, the Developer and Maker of AZT, a Drug